Therapy for Advanced NSCLC With EGFR 19delins Mutation
Fuzhou General Hospital
Fuzhou General Hospital
Shanghai Henlius Biotech
University of California, Davis
Radiopharm Theranostics, Ltd
Zhejiang University
Emory University
UNC Lineberger Comprehensive Cancer Center
Poitiers University Hospital
Karolinska University Hospital
Wondercel Biotech (ShenZhen)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Var2 Pharmaceuticals
TCRCure Biopharma Ltd.
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
University of Texas Southwestern Medical Center
University of Iowa
University of California, Davis
Peking Union Medical College Hospital
Institut Cancerologie de l'Ouest
Rutgers, The State University of New Jersey
Memorial Sloan Kettering Cancer Center
University of California, Irvine
NYU Langone Health
The University of Hong Kong-Shenzhen Hospital
Mayo Clinic
Guangzhou Ruixin Biotechnological Co., LTD
Assiut University
Guangdong Provincial People's Hospital
Sichuan University
Thunder Bay Regional Health Research Institute
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Second Affiliated Hospital of Nanchang University
Peking Union Medical College Hospital
Second Affiliated Hospital of Guangzhou Medical University
Second Affiliated Hospital of Guangzhou Medical University
Henan Cancer Hospital
University of Southern California
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Beijing Kejing Biotechnology Co., Ltd.
Second Affiliated Hospital, School of Medicine, Zhejiang University
Sichuan University
State University of New York - Upstate Medical University
Case Comprehensive Cancer Center
Fujian Cancer Hospital
Stanford University
Wake Forest University Health Sciences
Peking Union Medical College Hospital
Roswell Park Cancer Institute